145 related articles for article (PubMed ID: 36564257)
21. Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
Kim DW; Ahn H; Kim KW; Lee SS; Kim HJ; Ko Y; Park T; Lee J
Korean J Radiol; 2022 Nov; 23(11):1055-1066. PubMed ID: 36098341
[TBL] [Abstract][Full Text] [Related]
22. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
[TBL] [Abstract][Full Text] [Related]
23. Low skeletal muscle mass predicts relevant clinical outcomes in head and neck squamous cell carcinoma. A meta analysis.
Surov A; Wienke A
Ther Adv Med Oncol; 2021; 13():17588359211008844. PubMed ID: 34035838
[TBL] [Abstract][Full Text] [Related]
24. Predicting the Overall Survival in Patients with Advanced Pancreatic Cancer by Calculating L3 Skeletal Muscle Index Derived from CT.
Özkul B; Özkul Ö; Bilir C
Curr Med Imaging; 2022; 18(10):1079-1085. PubMed ID: 35240961
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of sarcopenia in patients with solid tumors: A meta-analysis based on 81,814 patients.
Surov A; Wienke A
JPEN J Parenter Enteral Nutr; 2022 Nov; 46(8):1761-1768. PubMed ID: 35633306
[TBL] [Abstract][Full Text] [Related]
26. Sarcopenia as a Prognostic Marker for Survival in Gastric Cancer Patients Undergoing Palliative Chemotherapy. A Systematic Review and Meta Analysis.
Meyer HJ; Wienke A; Surov A
Nutr Cancer; 2022; 74(10):3518-3526. PubMed ID: 35603926
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study.
Keyl J; Bucher A; Jungmann F; Hosch R; Ziller A; Armbruster R; Malkomes P; Reissig TM; Koitka S; Tzianopoulos I; Keyl P; Kostbade K; Albers D; Markus P; Treckmann J; Nassenstein K; Haubold J; Makowski M; Forsting M; Baba HA; Kasper S; Siveke JT; Nensa F; Schuler M; Kaissis G; Kleesiek J; Braren R
ESMO Open; 2024 Jan; 9(1):102219. PubMed ID: 38194881
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer.
Salinas-Miranda E; Deniffel D; Dong X; Healy GM; Khalvati F; O'Kane GM; Knox J; Bathe OF; Baracos VE; Gallinger S; Haider MA
Eur Radiol; 2021 Nov; 31(11):8662-8670. PubMed ID: 33934171
[TBL] [Abstract][Full Text] [Related]
29. Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
Schmeusser BN; Midenberg E; Palacios AR; Ali AA; Patil DH; Higgins M; Nabavizadeh R; Croll B; Williams M; Sheehy J; Zheng B; Narayan VM; Joshi SS; Ogan K; Psutka SP; Bilen MA; Master VA
Clin Genitourin Cancer; 2023 Aug; 21(4):475-482.e4. PubMed ID: 37210313
[TBL] [Abstract][Full Text] [Related]
30. Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis.
Ubachs J; Ziemons J; Minis-Rutten IJG; Kruitwagen RFPM; Kleijnen J; Lambrechts S; Olde Damink SWM; Rensen SS; Van Gorp T
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1165-1174. PubMed ID: 31389674
[TBL] [Abstract][Full Text] [Related]
31. Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis.
Bundred J; Kamarajah SK; Roberts KJ
HPB (Oxford); 2019 Dec; 21(12):1603-1612. PubMed ID: 31266698
[TBL] [Abstract][Full Text] [Related]
32. Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer.
Wu CH; Chang MC; Lyadov VK; Liang PC; Chen CM; Shih TT; Chang YT
Clin Nutr; 2019 Apr; 38(2):862-869. PubMed ID: 29503056
[TBL] [Abstract][Full Text] [Related]
33. Sarcopenia as a predictor of postoperative outcomes after urologic oncology surgery: A systematic review and meta-analysis.
Guo Z; Gu C; Gan S; Li Y; Xiang S; Gong L; Chan FL; Wang S
Urol Oncol; 2020 Jun; 38(6):560-573. PubMed ID: 32268990
[TBL] [Abstract][Full Text] [Related]
34. Influence of sarcopenia as defined by EWGSOP2 on complications after pancreaticoduodenectomy and on the prognosis of pancreatic head cancer: A prospective cohort study.
Aoki Y; Furukawa K; Suzuki D; Takayashiki T; Kuboki S; Takano S; Kawasaki Y; Shiko Y; Ohtsuka M
Nutrition; 2022; 99-100():111660. PubMed ID: 35576875
[TBL] [Abstract][Full Text] [Related]
35. Correlation between the skeletal muscle index and surgical outcomes of pancreaticoduodenectomy.
Sui K; Okabayshi T; Iwata J; Morita S; Sumiyoshi T; Iiyama T; Shimada Y
Surg Today; 2018 May; 48(5):545-551. PubMed ID: 29285616
[TBL] [Abstract][Full Text] [Related]
36. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
37. The Effect of Celiac Neurolysis and Splanchnicectomy on Survival in Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Ye L; Schorn S; Pergolini I; Safak O; Demir E; Istvanffy R; Friess H; Ceyhan GO; Demir IE
Dig Surg; 2022; 39(1):51-59. PubMed ID: 34903684
[TBL] [Abstract][Full Text] [Related]
38. The impact of sarcopenia on prognosis of patients with pancreatic cancer: A systematic review and meta-analysis.
Gan H; Lan J; Bei H; Xu G
Scott Med J; 2023 Nov; 68(4):133-148. PubMed ID: 37448350
[TBL] [Abstract][Full Text] [Related]
39. Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis.
Trejo-Avila M; Bozada-Gutiérrez K; Valenzuela-Salazar C; Herrera-Esquivel J; Moreno-Portillo M
Int J Colorectal Dis; 2021 Jun; 36(6):1077-1096. PubMed ID: 33481108
[TBL] [Abstract][Full Text] [Related]
40. The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery.
Rutten IJ; Ubachs J; Kruitwagen RF; van Dijk DP; Beets-Tan RG; Massuger LF; Olde Damink SW; Van Gorp T
Eur J Surg Oncol; 2017 Apr; 43(4):717-724. PubMed ID: 28159443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
